Krithika Chennapan, MD
Hematology & Oncology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chennapan’s office at (650) 934-7090 to ask if they take your plan before you enroll.
California Medical Board record
Licence A177499 · Current
Licensed to practise in California · since 2022 · expires 2028-06-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Medicaid work
$40,103 in 2023
Medicaid paid $40,103 for 357 billed services this clinician did in 2023, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 336 | $37,175 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 21 | $2,928 |
| 2023 | 357 | 2 | 35 | $40,103 |
| 2022 | 63 | 2 | 20 | $4,583 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 51 | $2,849 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $1,735 |
Drugs they prescribed that Part D paid
$316,766
Pharmacies billed $316,766 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
66 generic and 28 brand-name prescriptions · $316,766 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 94 | 40 | None | 30% | $316,766 |
| 2023 | 198 | 76 | 6% (11) | None | $75,382 |
| 2022 | 259 | 65 | None | 21% | $18,366 |
| 2021 | 328 | 52 | 0% (0) | None | $94,314 |
| 2020 | 90 | 24 | 0% (0) | 17% | $4,857 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 5 drugs
| Lantus Solostar | 11 | $1,355 | $123 |
| Atorvastatin | 11 | $182 | $17 |
| Metformin | 11 | $163 | $15 |
| Gabapentin | 11 | $155 | $14 |
| Diclofenac | 12 | $144 | $12 |
2021: 5 drugs
| Diclofenac | 26 | $542 | $21 |
| Gabapentin | 19 | $462 | $24 |
| Levothyroxine | 11 | $294 | $27 |
| Amlodipine Besylate | 14 | $196 | $14 |
| Famotidine | 14 | $129 | $9 |
Money from drug and device companies
$910 in 2025
| 2025 | 14 | 25 | None | $910 |
| 2024 | 9 | 12 | None | $389 |
| 2023 | 7 | 10 | None | $566 |
| 2022 | 1 | 1 | None | $135 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Incyte | Jakafi | $193 | 5 payments
|
| Novartis Pharmaceuticals | Scemblix | $170 | 4 payments
|
| Argenx US | None | $145 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $89 | 3 payments
|
| Servier Pharmaceuticals | Tibsovo | $50 | 2 payments
|
| EMD Serono | None | $48 | 1 payment
|
See all 25 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-17 | None | $31 |
| Novartis Pharmaceuticals | Meals · 2025-12-08 | Scemblix | $77 |
| Argenx US | Meals · 2025-11-19 | None | $145 |
| Incyte | Meals · 2025-11-04 | Jakafi | $28 |
| Agios Pharmaceuticals | Meals · 2025-10-16 | Pyrukynd | $15 |
| Novartis Pharmaceuticals | Meals · 2025-10-15 | Fabhalta | $33 |
| Incyte | Education · 2025-10-02 | None | $78 |
| Daiichi Sankyo | Meals · 2025-09-28 | Enhertu | $27 |
| Novartis Pharmaceuticals | Meals · 2025-09-25 | Fabhalta | $30 |
| Genentech USA | Meals · 2025-09-16 | Tecentriq | $26 |
| Janssen Biotech | Meals · 2025-08-26 | Darzalex | $24 |
| Incyte | Meals · 2025-08-12 | Jakafi | $29 |
| Merck Sharp & Dohme | Meals · 2025-08-05 | Keytruda | $31 |
| Incyte | Meals · 2025-07-17 | Monjuvi | $30 |
| Stemline Therapeutics | Meals · 2025-06-09 | Orserdu | $31 |
| Exelixis | Meals · 2025-05-20 | Cabometyx | $32 |
| Incyte | Meals · 2025-04-22 | Jakafi | $28 |
| Servier Pharmaceuticals | Meals · 2025-04-17 | Tibsovo | $25 |
| EMD Serono | Meals · 2025-03-11 | None | $48 |
| Celgene | Meals · 2025-03-06 | Reblozyl | $16 |
| Merck Sharp & Dohme | Meals · 2025-03-04 | Keytruda | $26 |
| Deciphera Pharmaceuticals | Meals · 2025-01-21 | Qinlock | $22 |
| Janssen Biotech | Meals · 2025-01-16 | Tecvayli | $23 |
| Servier Pharmaceuticals | Meals · 2025-01-09 | Tibsovo | $25 |
| Merck Sharp & Dohme | Meals · 2025-01-07 | Keytruda | $31 |
See earlier years (2024, 2023, 2022)
2024: $389
| Abbvie | Venclexta | $121 | 2 payments
|
| EMD Serono | None | $66 | 2 payments
|
| Daiichi Sankyo | Vanflyta | $47 | 2 payments
|
| Incyte | Jakafi | $30 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $28 | 1 payment
|
| Blueprint Medicines | Ayvakit | $28 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $27 | 1 payment
|
| Exelixis | Cabometyx | $24 | 1 payment
|
| Celgene | Reblozyl | $20 | 1 payment
|
2023: $566
| AstraZeneca Pharmaceuticals LP | Tagrisso | $124 | 1 payment
|
| Genzyme | Sarclisa | $122 | 4 payments
|
| Astellas Pharma US | Xospata | $115 | 1 payment
|
| AbbVie | Venclexta | $108 | 1 payment
|
| EMD Serono | Bavencio | $44 | 1 payment
|
| Daiichi Sankyo | Enhertu | $29 | 1 payment
|
| Celgene | Reblozyl | $24 | 1 payment
|
2022: $135
| Secura Bio | Copiktra | $135 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1497217111
- Licence
- CA A177499California A177499: Current · expires 2028-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2019-04-02
- NPI last updated
- 2026-09-14
- NPI record certified
- 2026-09-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1200 N State Street, Los Angeles, CA, 90033